CNS PHARMACEUTICALS INC's ticker is and the CUSIP is 18978H201. A total of 13 filers reported holding CNS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,999 | – | 21,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FSM Wealth Advisors, LLC | 19,084 | $21,756 | 0.01% |
| VANGUARD GROUP INC | 23,765 | $27,092 | 0.00% |
| UBS Group AG | 55 | $63 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 7 | $8 | 0.00% |
| WELLS FARGO & COMPANY/MN | 505 | $576 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 24,436 | $27,368 | 0.00% |
| STATE STREET CORP | 22,556 | $25,263 | 0.00% |
| MORGAN STANLEY | 67 | $76 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1 | $1 | 0.00% |